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See editorial on page 504.
ackground & Aims: Liver regeneration is a unique
esponse directed to restore liver mass after resection
r injury. The survival and proliferative signals trig-
ered during this process are conveyed by a complex
etwork of cytokines and growth factors acting in an
rderly manner. Activation of the epidermal growth
actor receptor is thought to play an important role in
iver regeneration. Amphiregulin is a member of the
pidermal growth factor family whose expression is
ot detectable in healthy liver. We have investigated
he expression of amphiregulin in liver injury and its
ole during liver regeneration after partial hepatec-
omy. Methods: Amphiregulin gene expression was
xamined in healthy and cirrhotic human and rat liver,
n rodent liver regeneration after partial hepatectomy,
nd in primary hepatocytes. The proliferative effects
nd intracellular signaling of amphiregulin were stud-
ed in isolated hepatocytes. The in vivo role of amphi-
egulin in liver regeneration after partial hepatectomy
as analyzed in amphiregulin-null mice. Results: Am-
hiregulin gene expression is detected in chronically
njured human and rat liver and is rapidly induced
fter partial hepatectomy in rodents. Amphiregulin
xpression is induced in isolated hepatocytes by in-
erleukin 1 and prostaglandin E2, but not by hepato-
yte growth factor, interleukin 6, or tumor necrosis
actor . We show that amphiregulin behaves as a
rimary mitogen for isolated hepatocytes, acting
hrough the epidermal growth factor receptor. Finally,
mphiregulin-null mice display impaired proliferative
esponses after partial liver resection. Conclusions:
ur findings indicate that amphiregulin is an early-
esponse growth factor that may contribute to the
nitial phases of liver regeneration.
ytoprotective and regenerating mechanisms are set
in motion in the liver after loss of parenchymal massue to partial hepatectomy (PH) or after tissue injury.1–3his complex response aimed at the restoration of liver-
ependent homeostasis is mediated by a network of
ytokines, comitogens, and growth factors in a coordi-
ated multistep process.2,3 Many of the mediators be-
ieved to be critical in the regenerative response to injury
r resection in animals are also expressed in humans
uring liver regeneration, thus suggesting the preserva-
ion of fundamental mechanisms across species.4
Despite the intensive research performed in the past
ew decades, the molecules and mechanisms involved in
he physiological adaptive response to liver injury are not
ompletely known. We have recently observed that the
xpression of the Wilms’ tumor suppressor 1 (WT1) gene
s induced in the livers of patients with hepatocellular
amage and in the livers of CCl4-treated rats.5 WT1
ncodes a zinc finger transcription factor that can regu-
ate the expression of a diversity of growth- and differ-
ntiation-related genes.6 One of the major physiological
argets directly induced by WT1 is amphiregulin (AR).7
R is a polypeptide growth factor of the epidermal
rowth factor (EGF) family and a ligand of the EGF
eceptor (EGF-R) that was originally isolated from con-
itioned medium of MCF-7 human breast carcinoma
ells treated with phorbol esters.8 Activation of the
GF-R in the hepatocyte is thought to play an important
ole during the early stages of liver regeneration after
Abbreviations used in this paper: AR, amphiregulin; BrdU, 5-bromo-
=-deoxyuridine; CRE, cyclic adenosine monophosphate–responsive el-
ment; EGF, epidermal growth factor; EGF-R, epidermal growth factor
eceptor; ERK, extracellular regulated kinase; FCS, fetal calf serum;
B-EGF, heparin-binding EGF-like growth factor; HGF, hepatocyte
rowth factor; IL, interleukin; JNK, c-Jun protein kinase; MEK, extracel-
ular regulated kinase kinase; p38 MAPK, p38 mitogen-activated pro-
ein kinase; PCNA, proliferating cell nuclear antigen; PCR, polymerase
hain reaction; PGE2, prostaglandin E2PH, partial hepatectomy; PI-3K,
hosphatidylinositol 3-kinase; TGF, transforming growth factor; TNF,
umor necrosis factor; WT1, Wilms’ tumor suppressor 1.

























































































February 2005 ROLE OF AMPHIREGULIN IN HEPATOCYTE PROLIFERATION 425H, and the levels of EGF-R ligands such as EGF and
ransforming growth factor (TGF)- are increased after
iver resection.1–4 The expression of AR is tissue specific:
t is most prevalent in human ovary and placenta but is
ndetectable in the healthy and quiescent liver paren-
hyma.9 Like EGF and TGF-, AR is synthesized as a
ransmembrane precursor that is proteolytically pro-
essed to the secreted mature form.10 AR shows bifunc-
ional properties, stimulating the proliferation of a vari-
ty of normal cells and inhibiting that of many tumor
ell lines.7,9,11 Together these observations prompted us
o examine AR gene expression in liver injury and during
xperimental liver regeneration. We show here that the
xpression of AR is detected in the liver of cirrhotic
atients and is rapidly induced in rodent liver after PH.
n addition, we show that AR behaves as a primary
itogen for the hepatocyte. A role for AR in the early
teps of liver regeneration is supported by the impaired
roliferative response of AR-null mice to PH. Our find-
ngs identify a novel function for AR in the liver and
uggest that this molecule may have therapeutic poten-




Liver tissue samples were from 2 groups of subjects.
he first group comprised control individuals (n  26; 19
en; mean age, 50.8 years; range, 18–73 years) with normal
r minimal changes in the liver. We collected tissue samples at
urgery (16 cases) of digestive tumors or from percutaneous
iver biopsy performed because of mild alteration of liver
unction tests (10 cases). The second group comprised subjects
ith liver cirrhosis (n  29; 24 men; mean age, 56 years;
ange, 36–77 years) that was due to hepatitis C virus infection
n 8 cases, alcohol abuse in 13 cases, hepatitis B virus infection
n 3 cases, autoimmune hepatitis in 3 cases, and hemochro-
atosis in 1 case and that was cryptogenic in another case.
ssociated hepatocellular carcinoma was present in 10 cir-
hotic patients. This study was approved by the Human Re-
earch Review Committee of the University of Navarra.
Animal Models
Liver cirrhosis was induced with CCl4 in male Wistar
ats (150 g) as previously described.12 Two-thirds PH or sham
perations were performed in male Wistar rats (150 g) and
ale AR/ and AR/ littermate mice13 (20 g) as previously
escribed.14,15 The AR/ mice, as described previously, are
iable and display no overt phenotype.13 One hour before
eing killed, mice were injected intraperitoneally with 50
g/kg of 5-bromo-2=-deoxyuridine (BrdU; Sigma, St. Louis,
O). This study was approved by our institution’s Animal
elfare Committee. (Isolation, Culture, and Treatment
of Rat Hepatocytes
Hepatocytes were isolated from male Wistar rats (150 g)
y collagenase (Gibco-BRL, Paisley, UK) perfusion as described
reviously.15 Cells were plated onto collagen-coated 6-well dishes
type I collagen; Collaborative Biomedical, Bedford, MA; 5  105
ells per well). Cultures were maintained in minimal essential
edium supplemented with 10% fetal calf serum (FCS), nones-
ential amino acids, 2 mmol/L glutamine, and antibiotics (all
rom Gibco-BRL). After 2 hours, incubation medium was re-
oved, and cells were refed the same medium with 0.5% FCS.
here indicated, hepatocytes were treated with interleukin
IL)-1 or tumor necrosis factor (TNF)- from Roche (Mann-
eim, Germany), hepatocyte growth factor (HGF) or forskolin
rom Calbiochem (San Diego, CA), IL-6 from R&D Systems
Wiesbaden-Nordenstadt, Germany), or prostaglandin E2 (PGE2)
rom Alexis (Carlsbad, CA).
Transient Transfection of Rat Hepatocytes
We seeded rat hepatocytes 24 hours before transfection
ith the Tfx-50 reagent (Promega, Madison, WI) according to
he manufacturer’s instructions, and cells were transfected in
uplicate with an equimolar mixture of pCB6 plasmids en-
oding the 4 isoforms of WT1 (characterized by the presence
r absence of the splice inserts, exon 5, and lysine, threonine,
erine [KTS]) or with an equivalent amount of the empty
CB6 vector, provided by Dr. Jochemsen (Leiden University
edical Center, Leiden, The Netherlands). Transfection effi-
iency was monitored by reverse-transcription polymerase
hain reaction (PCR) analysis by using specific primers that
iscriminated these 4 isoforms.
Assay of DNA Synthesis
Rat hepatocytes were plated at a density of 3  104
ells per well in collagen-coated 96-well plates in minimal
ssential medium supplemented with 10% FCS. Five hours
fter plating, medium was changed, and cells were kept in the
bsence of serum for 20 hours more. DNA synthesis was
easured in response to AR for 30 hours. A pulse of [3H]thy-
idine (1 Ci per well; Amersham Biosciences, Piscataway,
J) started 22 hours after AR addition. Cells were harvested,
nd [3H]thymidine incorporation was determined in a scintil-
ation counter. The effect of AR on DNA synthesis was also
ested in the presence of TGF- (Roche) or the extracellular
egulated kinase kinase (MEK)-1 inhibitor PD98059, the
hosphatidylinositol 3-kinase (PI-3K) inhibitor LY-294002,
he c-Jun protein kinase (JNK) inhibitor SP600125, the p38
itogen-activated protein kinase (p38 MAPK) inhibitor
B202190, and the EGF-R inhibitor PD153035, all from
albiochem.
RNA Isolation and Analysis of
Gene Expression
Total RNA was extracted by using the TRI Reagent




































































426 BERASAIN ET AL GASTROENTEROLOGY Vol. 128, No. 2Gibco-BRL) before reverse transcription with Moloney mu-
ine leukemia virus reverse transcriptase (Gibco-BRL) in the
resence of RNaseOUT (Gibco-BRL). PCR products were
lectrophoresed in 2% agarose gels, stained with ethidium
romide, and quantitated with Molecular Analyst software
Bio-Rad, Hercules, CA). Data were normalized to -actin
essenger RNA (mRNA) levels. Real-time PCR was per-
ormed with an iCycler (Bio-Rad) and the iQ SYBR Green
upermix (Bio-Rad). To monitor the specificity, final PCR
roducts were analyzed by melting curves and electrophoresis.
he identity of the PCR products was confirmed by sequence
nalysis. The comparative Ct method for relative quantitation
f gene expression was used (2Ct, where Ct represents the
ifference in threshold cycle between the target and control
enes). The primers used were designed according to published
omplementary DNA or genomic sequences.
Western Blot Analysis
and Immunohistochemistry
Homogenates from liver samples and isolated hepatocytes
ere subjected to Western blot analysis as described previously.15
ntibodies used were affinity-purified biotinylated anti-mouse
R polyclonal antibody (R&D Systems); phosphorylated Akt
Ser473) and phosphorylated signal transducer and activator of
ranscription 3 (Tyr705) (Cell Signaling, Beverly, MA); and extra-
ellular regulated kinase (ERK)-1/-2, phosphorylated EGF-R
Tyr1173), and signal transducer and activator of transcription 3
Upstate Biotechnology, Charlottesville, VA). Antibodies for
GF-R, -actin, phosphorylated ERK-1/-2 (Tyr204), Akt, JNK,
hosphorylated JNK (Thr183/Tyr185), proliferating cell nuclear
ntigen (PCNA), and cyclin D1 were from Santa Cruz Biotech-
ology (Santa Cruz, CA). Immunohistochemical detection and
uantitation of BrdU incorporation into cellular DNA was per-
ormed in formalin-fixed and paraffin-embedded liver tissue as
escribed previously.16
Statistical Analysis
Normally distributed data were compared among groups
y using an independent Student t test and 1-way analysis of
ariance. Nonnormally distributed data were compared by using
he Kruskal–Wallis and Mann–Whitney tests. Correlation was
ssessed by Spearman or Pearson correlation coefficients. Data are
eported as means 	 SEM or as medians and interquartile ranges.
P value of 
 .05 was considered significant.
Results
Amphiregulin Gene Expression Is Induced
in Human and Experimental Liver Injury
We have previously shown that expression of the
ranscription factor WT1 is induced in almost all tested
amples of cirrhotic human liver and always in CCl4-
nduced cirrhosis in rats.5 The fact that AR is a major
ranscriptional target for WT17 led us to examine the
xpression of this growth factor in the liver of cirrhotic eatients. Although real-time PCR analysis showed barely
etectable levels of AR expression in healthy human
iver, AR gene expression was observed in approximately
5% of patients with cirrhosis (Figure 1A). It is inter-
sting to note that the levels of AR gene expression
irectly correlated with those of WT1 in the liver of
ontrol and cirrhotic subjects (r  0.752; P 
 .001). In
ccordance with data in humans, AR gene expression was
lso observed in experimental cirrhosis induced in rats by
Cl4 administration (Figure 1B).
Amphiregulin Gene Expression in the Liver
After Partial Hepatectomy
The fact that AR is a growth factor and a ligand of
he EGF-R suggested that its induction in the damaged
iver could be part of the regenerative response of the
amaged organ triggered during chronic injury. To directly
valuate this possibility, we used the well-characterized
odel of rat liver regeneration after two-thirds PH.4,14 As
hown in Figure 2A, AR mRNA was absent in the rat liver
efore PH, became detectable as early as 0.5 hours after the
ntervention, peaked by 6 hours, and steadily decreased
etween 15 and 24 hours. In sham-operated rats, AR gene
igure 1. (A) AR gene expression in human liver cirrhosis. AR gene
xpression was measured by real-time PCR in liver samples from
ontrol individuals (n  26) and cirrhotic patients (n  29). (B) AR
ene expression in control and in CCl4-cirrhotic rat liver as determined
y semiquantitative reverse-transcription polymerase chain reaction


















































February 2005 ROLE OF AMPHIREGULIN IN HEPATOCYTE PROLIFERATION 427ut to a much lesser extent than in resected animals (Figure
A). In mouse liver, AR gene expression was also readily
nduced after PH. AR mRNA levels were up-regulated 0.5
ours after PH, reached a peak between 24 and 48 hours,
nd subsequently decreased (data not shown). Using a bio-
inylated affinity-purified anti-AR antibody, we detected a
and of approximately 50 kilodaltons that was induced in
at liver at 1 hour after PH (inset in Figure 2A). This band
s consistent with the molecular weight of the membrane-
nchored AR precursor previously described in epithelial
ells.10
In an attempt to identify the mechanisms respon-
ible for the induction of AR mRNA levels in the
egenerating liver, we isolated rat hepatocytes and
xamined AR gene expression under different condi-
ions. We tested the effect of several factors and
ediators released early after PH that are believed to
lay a relevant role in liver regeneration, such as
L-1, IL-6, TNF-, HGF, and PGE2.1– 4,17,18 Among
he cytokines and growth factors tested, IL-1 was the
nly one that stimulated AR gene expression (Figure
igure 2. (A) AR gene expression was analyzed by semiquantitative
arenchyma at different time points after PH or sham operation (SH).
R precursor protein as detected by Western blotting. Representativ
reated with IL-1 (2 ng/mL) or (C) PGE2 (10 mol/L) for different
everse-transcription polymerase chain reaction. *P 
 .05 vs contro
riplicate. (D) Expression of AR in rat hepatocytes 24 hours after tr
soforms of WT1 or with an equivalent amount of the empty pCB6 ve
EM of 3 experiments performed in triplicate.B). It is interesting to note that IL-1 treatment of Wsolated hepatocytes did not induce the expression of
ther EGF-R ligands produced by the hepatocyte,
uch as TGF- (data not shown). In agreement with
revious observations made in colon cancer cells,19 we
oticed that treatment of rat hepatocytes with PGE2
esulted in the rapid induction of AR gene expression
Figure 2C). It has been postulated that PGE2 stimu-
ation of AR gene expression is signaled through the
yclic adenosine monophosphate (cAMP)/protein ki-
ase A pathway acting on a cAMP-responsive element
CRE) in the AR gene promoter.19 Consistent with
his mechanism, we observed that the cAMP-inducing
gent forskolin promoted AR gene expression in iso-
ated hepatocytes (data not shown).
As we previously mentioned, AR is a bona fide target for
he transcription factor WT1.7 We found that transfection
f hepatocytes with an equimolar mixture of pCB6 plasmids
ncoding the 4 isoforms of WT1 resulted in the up-regu-
ation of AR mRNA levels, as determined by real-time PCR
Figure 2D). This observation shows that WT1 can mediate
R expression in liver parenchymal cells, suggesting that
se-transcription polymerase chain reaction in the remaining rat liver
s are means 	 SEM of 3 different animals. (Inset) The 50-kilodalton
mples are shown. (B) Expression of AR in isolated rat hepatocytes
ds of time. AR gene expression was analyzed by semiquantitative
en bars). Values are means 	 SEM of 3 experiments performed in
ction with an equimolar mixture of pCB6 plasmids encoding the 4

















































428 BERASAIN ET AL GASTROENTEROLOGY Vol. 128, No. 2xpression observed in chronic liver damage. However, the
nduction of AR gene expression in the regenerating liver
fter PH seems to be independent of WT1, because the
xpression of the latter gene is not induced after liver
esection (data not shown).
Amphiregulin Induces DNA Synthesis in
Isolated Hepatocytes
Having shown that AR gene expression is induced
n the injured and regenerating liver, we next tested the
ffect of this growth factor on isolated parenchymal cells. As
epicted in Figure 3A, AR behaved as a primary mitogen
or the hepatocyte, stimulating [3H]thymidine incorpora-
ion into DNA in a dose-dependent fashion. The effect of
R on DNA synthesis was abrogated by TGF-, a growth
actor implicated in the physiological termination of the
iver regenerative response.1
As previously mentioned, AR is a ligand of the EGF-R,
receptor that is highly expressed in adult hepatocytes.20,21
igure 3. (A) Stimulation of DNA synthesis by AR in cultured rat hepatoc
f TGF- (8 ng/mL) on AR-induced DNA synthesis is shown. Values are
.01 vs control. (B) Stimulation of EGF-R tyrosine phosphorylation by AR
GF-R were detected by Western blotting. Representative blots of 3 e
RK-1/-2, and JNK in rat hepatocytes at different times after AR additio
erformed in duplicate are shown. (D) Effect of AR (100 nmol/L) on DNA
1 mol/L), the MEK-1 inhibitor PD98059 (10 mol/L), the PI-3K inhibit
38 MAPK inhibitor SB202190 (25 mol/L). *P 
 .05 vs AR alone. Van agreement with this, treatment of isolated rat hepato- (ytes with AR induced rapid and transient tyrosine phos-
horylation of the EGF-R (Figure 3B). The MEK/ERK and
I-3K pathways are viewed as the main signaling cascades
n the mitogenic response of hepatocytes to growth fac-
ors.22–25 More recently, JNK activation has been shown to
ignificantly contribute to hepatocyte proliferation after
H.26 We observed that stimulation of isolated rat hepato-
ytes with AR rapidly induced ERK-1/-2 and Akt phos-
horylation (Figure 3C). In addition, we observed that JNK
as phosphorylated in response to AR treatment (Figure
C). To evaluate the relative contribution of these signaling
athways to AR-induced DNA synthesis in rat hepatocytes,
e made use of different specific inhibitors. As depicted in
igure 3D, the EGF-R tyrosine kinase inhibitor PD153035
ompletely prevented AR-stimulated DNA synthesis. A
imilar degree of inhibition was observed for the PI-3K
nhibitor LY-294002, whereas the MEK-1 PD98059 and
NK SP600125 inhibitors reduced AR effects by 70%
DNA synthesis was measured as [3H]thymidine incorporation. The effect
s 	 SEM of 3 experiments performed in quadruplicate. *P 
 .05; **P
tured rat hepatocytes. Tyrosine-phosphorylated EGF-R (P-EGFR) and total
ments performed in duplicate are shown. (C) Phosphorylation of Akt,
assessed by Western blotting. Representative blots of 3 experiments
esis in rat hepatocytes in the presence of the EGF-R inhibitor PD153035
294002 (20 mol/L), the JNK inhibitor SP600125 (20 mol/L), or the









































February 2005 ROLE OF AMPHIREGULIN IN HEPATOCYTE PROLIFERATION 429APK by AR treatment, the p38 MAPK inhibitor
B202190 had no significant effect on AR-stimulated
NA synthesis (Figure 3D).
Role of Amphiregulin in Liver Regeneration
After Partial Hepatectomy
To directly evaluate the significance of AR gene
xpression during liver regeneration after PH, we used
R/ mice.13 There were no significant differences in
urvival after PH between AR/ and AR/ mice. We first
ested the DNA synthetic response in AR/ and AR/
nimals after two-thirds PH. BrdU incorporation was de-
ected by immunohistochemistry to evaluate the number of
ells in S phase at different times after PH. As shown in
igure 4A, BrdU incorporation into DNA was significantly
educed and delayed in AR-null mice, reflecting impaired
NA synthesis. In agreement with this observation, the
nduction of PCNA expression, a landmark of S phase, was
elayed in AR/ mice after PH (Figure 4B). It is interest-
ng to note that although delayed, the induction of PCNA txpression in AR/ mice seemed higher than in AR/
ice (Figure 4B). A similar feature has also been observed
ecently in conditional Met mutant mice during liver re-
eneration.27 These mice display a delayed but more pro-
ounced increase in PCNA levels after liver resection, and
his situation accompanies a severely impaired DNA syn-
hetic response.27
To assess whether the observed decrease in DNA
ynthesis was the consequence of impaired progression of
epatocytes through the G1/S boundary, we measured
he protein levels of cyclin D1. We observed that the
xpression of cyclin D1 was similar in AR/ and AR/
nimals; however, its induction was significantly delayed
n the AR/ mice (Figure 4B). AR/ mice also showed
ifferential immediate-early gene activation 2 hours after
H when compared with wild-type animals, as evi-
enced by the reduced levels of c-fos, Egr-1, and c-myc
RNAs (Figure 4C). Impairment in the activation of
re 4. Response of AR/ mice to two-thirds PH. (A) Immunohisto-
mical detection of BrdU in liver sections of AR/ and AR/ mice at
hours after PH. Representative images (20 fields) of 4 mice per
t are shown. BrdU-labeled hepatocytes were quantitated by counting
itively stained cells in 3 low-magnification fields. Data are expressed
the percentage of BrdU-positive hepatocytes quantitated per 100
atocytes. Four animals were studied for each time point and geno-
. Data are means 	 SEM. *P 
 .05 vs AR/ mice. (B) Western blot
lysis of cyclin D1 and PCNA in AR/ and AR/ mice at different time
ts after PH. Representative blots of 4 animals per point are shown.
Expression of the immediate-early response genes c-fos, c-myc, and
1 analyzed by real-time PCR in the liver of AR/ and AR/ mice 2











































































































430 BERASAIN ET AL GASTROENTEROLOGY Vol. 128, No. 2uction of AR gene expression shortly after liver resec-
ion. Together these observations suggest that the early
nduction of AR gene expression after PH is necessary for
he normal onset of liver regeneration and cannot be
ompensated for by other EGF-R ligands.
Discussion
The loss of functional liver mass induced by tox-
ns, viral infections, or tissue resection triggers a well-
rchestrated regenerative response that involves a num-
er of cytokines, growth factors, hormones, and
etabolites.1–4 The identities of many of these factors
ave been established over the past decades, but the
omplexity of this response likely involves additional
layers. Here we provide several lines of evidence sup-
orting AR, a ligand of the EGF-R, as a new factor
nvolved in liver regeneration.
Our previous findings showed that expression of the
ranscription factor WT1 was induced in human and
xperimental liver damage.5 The fact that AR is probably
he best-characterized physiological target activated by
T17 prompted us to examine whether AR expression,
hich is barely detectable in the healthy liver, could be
p-regulated in the injured liver. We observed that AR
ene transcription was induced in human and experi-
ental liver cirrhosis, correlating with the expression of
T1. Because AR is a ligand of the EGF-R, we specu-
ated that its expression in chronic liver injury could be
art of the compensatory response of this organ aimed at
he restoration of liver mass. To investigate whether the
resence of AR was related to the regenerative process,
e examined the expression of this gene in the well-
stablished model of liver regeneration after two-thirds
H. We noticed that AR gene expression was induced
ery quickly after tissue resection both in rats and mice.
he expression of AR before DNA synthesis after PH
uggests that this factor could play an early role in liver
egeneration.
Experiments conducted in isolated rat hepatocytes
videnced that AR can interact directly with the paren-
hymal liver cells and trigger growth signals. Our in
itro experiments also showed that activation of the
GF-R by AR was necessary to convey this mitogenic
ffect. Hepatocyte proliferation in response to other
GF-R ligands, such as EGF and TGF-, involves the
ctivation of different signaling pathways, including
embers of the MAPK family, such as ERK-1/-2, JNK,
nd p38, and the PI-3K-FK506-binding protein-12-
apamycin associated protein (FRAP)/mammalian target
f rapamycin (mTOR) pathway. However, some contro-
ersies exist as to their relative contribution to DNA leplication in hepatocytes.22–26 In agreement with previ-
us reports on EGF-induced hepatocyte prolifera-
ion,22–26 we observed that AR stimulated ERK-1/-2,
NK, and Akt phosphorylation (a downstream target of
I-3K) and that in the presence of specific inhibitors of
hese pathways, AR-induced DNA synthesis was de-
reased. Although we did not test p38 activation by AR
reatment, stimulation of DNA synthesis by AR was not
ffected by a p38 MAPK inhibitor, thus suggesting that
his kinase is not involved in AR mitogenic effects.
Using primary cultured hepatocytes, we have ad-
ressed the potential signaling mechanisms responsible
or the induction of AR gene expression in the liver. We
ested the effect of different cytokines, growth factors,
nd mediators involved in the early phases of liver re-
eneration after injury and PH. We observed that IL-1
reatment significantly increased AR mRNA levels in
solated hepatocytes. The induction of the AR gene ex-
ression by IL-1 in cultured cells is consistent with the
arly production of this cytokine in different experimen-
al models of liver injury and regeneration in which we
bserved AR up-regulation.17,28 In contrast, IL-6,
NF-, and HGF failed to activate AR gene expression
n isolated hepatocytes. It is interesting to note that
NF-29 and HGF,30 but not IL-1 (unpublished data),
re able to induce the expression of other EGF-R ligands,
uch as TGF-, in hepatocytes. Together these observa-
ions attest to the diversity of signals involved in the
egulation of the apparently redundant pathways in-
olved in liver regeneration.
Prostaglandins are produced in the liver very early
fter PH and are necessary for a successful regenerative
esponse.18 It has been recently reported that the expres-
ion of AR in colon cancer cells is induced by PGE2
enerated by cyclooxygenase 2.19 Now we show that
GE2 can also stimulate the expression of AR in the
epatocyte. The effect of PGE2 on AR gene transcription
n colon cancer cells is mediated through the cAMP/
rotein kinase A pathway acting on a CRE in the AR
romoter.9,19 In line with these observations, we noticed
hat increased intracellular cAMP levels also promoted
R gene expression in hepatocytes. It is interesting to
ote that transfection of hepatocytes with an expression
ector harboring WT1 complementary DNA promoted
he accumulation of AR mRNA. It is worth mentioning
hat WT1 seems to activate the same CRE site in the AR
romoter that is involved in PGE2-mediated AR tran-
cription.9,19 Altogether, these experiments lend support
o the hypothesis that in the chronically injured liver, the
nduction of AR gene expression can be mediated in part
y WT1 up-regulation, whereas in situations of acute



























































February 2005 ROLE OF AMPHIREGULIN IN HEPATOCYTE PROLIFERATION 431xpression is not detected; data not shown), other medi-
tors, such as IL-1 and PGE2, may promote AR gene
xpression. Finally, our observations regarding the in-
ucibility of AR gene expression in isolated hepatocytes
re in agreement with a previous report showing the
roduction of AR by spontaneously growing hepatocytes
n hepatic organoid cultures.31
Rapid tyrosine phosphorylation of the EGF-R occurs
hortly after PH in rats.1 This fact, together with the
itogenic potential of EGF-R ligands for hepatocytes in
ulture, suggests a significant role for EGF-R activation
n the early stages of liver regeneration.1–4 The expres-
ion of other EGF-R ligands and hepatocyte mitogens,
uch as TGF- and heparin-binding EGF-like growth
actor (HB-EGF), has been previously examined in rat
iver after PH.32,33 Maximal TGF- expression occurs 24
ours after PH, whereas peak HB-EGF mRNA levels are
etected 6 hours after liver resection. Similar to what has
een described for HB-EGF, we have found that AR gene
xpression is rapidly induced in the liver of rats after PH.
xperiments performed in TGF-–null mice indicated
hat this factor was not necessary for liver regeneration.34
he normal response to PH observed in these mice was
ttributed to the compensatory increase in other mem-
ers of the EGF-R family of ligands, such as EGF.34
nother good candidate besides AR would be HB-EGF;
owever, the physiological role of HB-EGF in liver re-
eneration has not yet been tested in the HB-EGF–null
ouse.35 Our present findings indicate the lack of AR
esults in deregulation of cell cycle–associated mecha-
isms resulting in impaired DNA synthesis after liver
esection. The blunted induction of immediate-early
enes in AR/ mice reflects the involvement of this
rowth factor in the very early steps of hepatocyte pro-
iferation. It is interesting to note that the induction of
mmediate-early genes such as c-fos is not altered in the
iver of a conditional Met mutant mouse model after
H.27 The existence of other growth factor signaling
athways cooperating with HGF/c-met in the early con-
rol of hepatocyte proliferation has been also suggested in
n independent study with conditional Met mutant
ice.36 Our present data suggest that AR, probably
ogether with other cytokines such as IL-6,3 could be
esponsible for this effect. Taken together, our observa-
ions indicate that AR is a new player in liver regener-
tion and has a prominent role in triggering the early
hases of this process.
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